These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 2964559

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The Ca2+-pumping ATPase of heart sarcolemma. Characterization, calmodulin dependence, and partial purification.
    Caroni P, Carafoli E.
    J Biol Chem; 1981 Apr 10; 256(7):3263-70. PubMed ID: 6451626
    [Abstract] [Full Text] [Related]

  • 6. Calmodulin-dependent Ca2+-pump ATPase of human smooth muscle sarcolemma.
    Popescu LM, Ignat P.
    Cell Calcium; 1983 Oct 10; 4(4):219-35. PubMed ID: 6315240
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of Ca2+-dependent protein kinase and Ca2+/Mg2+-ATPase in cardiac sarcolemma by the anti-calmodulin drug calmidazolium.
    Lamers JM, Stinis JT.
    Cell Calcium; 1983 Oct 10; 4(4):281-94. PubMed ID: 6139171
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Ca2+-calmodulin-dependent phosphorylation and passive transport of Ca2+ in the myocardial sarcolemma].
    Vorobets ZD, Kurskiĭ MD, Marchenko SN.
    Biokhimiia; 1984 Aug 10; 49(8):1268-74. PubMed ID: 6149768
    [Abstract] [Full Text] [Related]

  • 10. Distinct mechanisms of inhibition of purified cardiac sarcolemma Ca(2+)-ATPase by two calmodulin antagonists.
    Pasa TC, Otero A, Barrabin H, Scofano HM.
    Biochem Pharmacol; 1992 Apr 15; 43(8):1797-803. PubMed ID: 1533519
    [Abstract] [Full Text] [Related]

  • 11. Calcium channel blocker inhibition of the calmodulin-dependent effects of thyroid hormone and milrinone on rabbit myocardial membrane Ca2+-ATPase activity.
    Warnick PR, Davis FB, Mylotte KM, Davis PJ, Dube MP, Blas SD.
    Biochem Pharmacol; 1988 Jul 01; 37(13):2619-23. PubMed ID: 2968801
    [Abstract] [Full Text] [Related]

  • 12. Stimulation of canine cardiac sarcoplasmic reticulum Ca2+ uptake by dihydropyridine Ca2+ antagonists.
    Movsesian MA, Ambudkar IS, Adelstein RS, Shamoo AE.
    Biochem Pharmacol; 1985 Jan 15; 34(2):195-201. PubMed ID: 3155615
    [Abstract] [Full Text] [Related]

  • 13. Protein kinase C mediated activation and phosphorylation of Ca(2+)-pump in cardiac sarcolemma.
    Qu Y, Torchia J, Sen AK.
    Can J Physiol Pharmacol; 1992 Sep 15; 70(9):1230-5. PubMed ID: 1337308
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Calcium transport systems in cardiac sarcolemma and their regulation by the second messengers cyclic AMP and calcium-calmodulin.
    Lamers JM.
    Gen Physiol Biophys; 1985 Apr 15; 4(2):143-54. PubMed ID: 2993098
    [Abstract] [Full Text] [Related]

  • 17. Two site binding of bepridil and modulation of adenylate cyclase in cardiac sarcolemmal membranes.
    Cramb G, Dow JW.
    Biochim Biophys Acta; 1983 Dec 07; 736(1):99-108. PubMed ID: 6317030
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The sarcolemmal Ca2+-ATPase of the ischemic-reperfused myocardium: protective effect of hypocalcemia on calmodulin-stimulated activity.
    Samouilidou EC, Karli JN, Levis GM, Darsinos JT.
    Life Sci; 1998 Dec 07; 62(1):29-36. PubMed ID: 9444965
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.